Status:
COMPLETED
Fluticasone Nasal Spray Patient Preference Study
Lead Sponsor:
GlaxoSmithKline
Conditions:
Rhinitis, Allergic, Perennial
Eligibility:
All Genders
18+ years
Phase:
PHASE3
Brief Summary
The objectives of this study are to evaluate and compare patient preference for FF (Fluticasone Furoate) and FP (Fluticasone Propionate Aqueous)nasal sprays in the treatment of allergic rhinitis follo...
Eligibility Criteria
Inclusion
- allergic rhinitis
- literate
Exclusion
- clinical significant uncontrolled disease
- Use of intranasal corticosteroids (\<4 weeks of FP \[branded or generic\],\<4 week exposure to FF, \<4 weeks use of other INS)
- Use of intranasal medications \<1 week
- Use of meds that significantly inhibit CYP4503A4
- Use of perfume or oral rinse on study day
- Allergy/intolerance to INS, antihistamines, or excipients
- Positive pregnancy test or female who is breastfeeding
- Affiliation with investigational site
Key Trial Info
Start Date :
December 1 2006
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 4 2006
Estimated Enrollment :
127 Patients enrolled
Trial Details
Trial ID
NCT00398476
Start Date
December 1 2006
End Date
December 4 2006
Last Update
March 1 2018
Active Locations (14)
Enter a location and click search to find clinical trials sorted by distance.
1
GSK Investigational Site
Fountain Valley, California, United States, 92708
2
GSK Investigational Site
Long Beach, California, United States, 90808
3
GSK Investigational Site
San Diego, California, United States, 92123
4
GSK Investigational Site
Denver, Colorado, United States, 80230